The struggling biotech firm, NovaGen Therapeutics, faced severe fiscal difficulties stemming from disappointing clinical trials and mounting debt. Their internal management lacked the expertise to navigate the complex landscape of biotech investment. Engaging specialized CFO support for biotech p